LEF inhibits osteopontin (OPN)/transforming growth factor beta 1 (TGF-β1)-mediated extracellular matrix deposition, tubular interstitial fibrosis, and tubular epithelial–mesenchymal transdifferentiation to reduce kidney injury in diabetic rats (6). This evidence concerns the gene TGFB1 and fibrosis.